Table 3.
CRS-207 infusion–related adverse events by patienta (N = 38)
| Infusion-related adverse events | Grade 1 n (%) | Grade 2 n (%) | Grade 3 n (%) | Total; n (%) |
|---|---|---|---|---|
| Chills/rigor | 6 (16%) | 29 (76%) | 2 (5%) | 37 (97%) |
| Pyrexia | 21 (55%) | 15 (39%) | 1 (3%) | 37 (97%) |
| Nausea | 21 (55%) | 5 (13%) | 0 (0%) | 26 (68%) |
| Vomiting | 13 (34%) | 5 (13%) | 0 (0%) | 17 (45%) |
| Hypotension | 5 (13%) | 1 (3%) | 1 (3%) | 7 (18%) |
No grade 4 CRS-207 infusion–related adverse event was observed.